SINOPHARM: Sinopharm Accord's net profit attributable to shareholders for the first three quarters was 957 million yuan, a year-on-year decrease of 10.18%
I'm PortAI, I can summarize articles.
SINOPHARM announced the performance of Sinopharm Accord for the first three quarters of 2025, with operating revenue of 55.124 billion yuan, a year-on-year decrease of 2.38%; net profit attributable to the parent company of 959 million yuan, a year-on-year decrease of 10.18%; and basic earnings per share of 1.72 yuan. In the third quarter of 2025, operating revenue was 18.328 billion yuan, a year-on-year decrease of 1.89%; net profit attributable to the parent company was 291 million yuan, a year-on-year decrease of 9.58%
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments